Position in INVA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$22,041
+$2,471 QoQ
Shares Held
946
-3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WealthCollab, LLC holds $155,531 across 21 Biotechnology names. INVA ranks #2 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
583 | $25,004 | |
| 2 | INVA |
Innoviva, Inc.
This page
|
946 | $22,041 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
69 | $13,044 | |
| 4 | INCY |
Incyte Corp
|
124 | $11,670 | |
| 5 | ARGX |
Argenx SE
|
14 | $10,223 | |
| 6 | MRNA |
Moderna, Inc.
|
200 | $10,160 | |
| 7 | GMAB |
Genmab A/S
|
357 | $9,578 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
200 | $9,514 |
All Filings in INVA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,041 | 946 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $19,570 | 979 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $17,866 | 979 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $22,179 | 1,104 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $20,015 | 1,104 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $18,269 | 1,053 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $20,333 | 1,053 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,269 | 1,053 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,047 | 1,053 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $14,885 | 928 | Shares | Defined | 2024-04-03 | |
| No filing history on record for this holder in this stock. | ||||||